Mariotto, Sara
 Distribuzione geografica
Continente #
NA - Nord America 7.532
EU - Europa 6.267
AS - Asia 5.297
SA - Sud America 848
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 197
OC - Oceania 30
AN - Antartide 1
Totale 20.469
Nazione #
US - Stati Uniti d'America 7.311
RU - Federazione Russa 2.947
SG - Singapore 2.121
CN - Cina 1.392
IT - Italia 887
BR - Brasile 671
GB - Regno Unito 628
VN - Vietnam 520
HK - Hong Kong 440
DE - Germania 333
FR - Francia 328
SE - Svezia 306
IE - Irlanda 305
KR - Corea 173
FI - Finlandia 167
BD - Bangladesh 159
CA - Canada 120
IN - India 95
AR - Argentina 72
JP - Giappone 63
ID - Indonesia 62
NL - Olanda 51
UA - Ucraina 49
PL - Polonia 48
ES - Italia 47
ZA - Sudafrica 47
MX - Messico 43
BE - Belgio 39
TR - Turchia 39
IQ - Iraq 36
AT - Austria 32
TG - Togo 29
AU - Australia 27
NG - Nigeria 27
BJ - Benin 25
PK - Pakistan 25
EC - Ecuador 24
IR - Iran 23
CL - Cile 20
CO - Colombia 19
MA - Marocco 19
SA - Arabia Saudita 19
JM - Giamaica 18
LT - Lituania 18
VE - Venezuela 18
UZ - Uzbekistan 17
AE - Emirati Arabi Uniti 15
PH - Filippine 13
EG - Egitto 11
KE - Kenya 10
CH - Svizzera 9
IL - Israele 9
JO - Giordania 9
PY - Paraguay 9
RO - Romania 8
TN - Tunisia 8
CR - Costa Rica 7
NP - Nepal 7
PT - Portogallo 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
UY - Uruguay 6
HR - Croazia 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
AL - Albania 4
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
GR - Grecia 4
LU - Lussemburgo 4
ML - Mali 4
PA - Panama 4
PS - Palestinian Territory 4
SV - El Salvador 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DK - Danimarca 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
KW - Kuwait 3
LK - Sri Lanka 3
LV - Lettonia 3
MD - Moldavia 3
RS - Serbia 3
TH - Thailandia 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
GE - Georgia 2
GT - Guatemala 2
Totale 20.134
Città #
Ashburn 1.115
Singapore 1.089
Moscow 1.022
San Jose 796
Dallas 717
Chandler 690
Hong Kong 435
Southend 414
Verona 330
Beijing 309
Council Bluffs 308
Dublin 291
The Dalles 229
New York 195
Los Angeles 175
Ho Chi Minh City 174
Woodbridge 157
Jacksonville 135
Ann Arbor 111
Hanoi 108
Lawrence 98
Princeton 98
Wilmington 88
Helsinki 79
Santa Clara 77
Houston 75
Munich 73
Jinan 71
Buffalo 67
Dearborn 66
Milan 63
Redondo Beach 62
São Paulo 62
London 56
Shenyang 55
Nanjing 53
Redmond 53
Sindelfingen 52
Tokyo 48
Orem 47
Columbus 45
Warsaw 45
Hebei 43
Washington 43
Tianjin 42
Jakarta 41
Montreal 41
Chicago 39
Phoenix 39
Brooklyn 38
Dong Ket 36
Seattle 36
Brussels 34
Guangzhou 34
Rome 33
Seoul 33
Bologna 32
Lappeenranta 31
Boardman 30
Denver 29
Frankfurt am Main 29
Lomé 29
Nuremberg 29
Atlanta 27
Changsha 27
Ningbo 27
Turku 26
Abuja 25
Cotonou 25
Toronto 25
Amsterdam 24
Johannesburg 24
Zhengzhou 24
Hangzhou 23
Adelaide 22
Belo Horizonte 22
Chennai 22
Nanchang 22
Falls Church 21
Rio de Janeiro 21
Taiyuan 21
Haiphong 20
Mexico City 20
Poplar 20
Boston 19
Da Nang 19
Paris 19
Haikou 18
Kent 18
Florence 16
Redwood City 16
Stockholm 16
Taizhou 16
Vienna 16
Baghdad 15
Mumbai 15
Norwalk 15
Kingston 14
Manchester 14
Bloomsbury 13
Totale 11.721
Nome #
Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study 266
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 259
What is the role of the placebo effect for pain relief in neurorehabilitation? Clinical implications from the Italian Consensus Conference on Pain in Neurorehabilitation 253
Cyclooxygenase 2, toll-like receptor 4 and interleukin 1beta mRNA expression in atherosclerotic plaques of type 2 diabetic patients. 238
Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders 234
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 228
A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band 217
A 58-year-old man with B-cell chronic lymphocytic leukemia and multiple strokes 216
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 215
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases 214
Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder 212
Time for a Consensus Conference on pain in neurorehabilitation 211
Anti-N-methyl-d-aspartate receptor encephalitis causing a prolonged depressive disorder evolving to inflammatory brain disease. 210
Brentuximab vedotin: axonal microtubule's Apollyon 210
Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation 202
Neurosyphilis manifesting with rapidly progressive dementia: report of three cases. 199
Clinical and neurophysiological serial assessments of brentuximab vedotin-associated peripheral neuropathy 198
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 194
Cauda equina syndrome caused by lumbosacral epidural lipomatosis. A case report. 190
Nervous system: subclinical target of SARS-CoV-2 infection 188
Microglial and Neuronal TDP-43 Pathology in Anti-IgLON5-Related Tauopathy 187
Neurological symptoms and axonal damage in COVID-19 survivors: are there sequelae? 182
Acute cervical longitudinally extensive transverse myelitis in a child with Lipopolysaccharide-Responsive-Beige-Like-Anchor-Protein (LRBA) deficiency: a new complication of a rare disease 181
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors? 181
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 179
Neurological complications in adult allogeneic hematopoietic stem cell transplant patients: Incidence, characteristics and long-term follow-up in a multicenter series 176
A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders 175
Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype 174
Sural nerve biopsy: current role and comparison with serum neurofilament light chain levels 174
Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis 172
Antibodies to MOG in CSF only: pathological findings support the diagnostic value 172
MOG antibody seropositivity in a patient with encephalitis: beyond the classical syndrome 170
The original histological slides of Camillo Golgi and his discoveries on neuronal structure 166
Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies 163
Association of Maintenance Intravenous Immunoglobulin With Prevention of Relapse in Adult Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease 163
Mycobacterium avium subspecies paratuberculosis and myelin basic protein specific epitopes are highly recognized by sera from patients with Neuromyelitis optica spectrum disorder 161
Hypothalamic-Bulbar MRI hyperintensity in Anti-IgLON5 disease with serum-restricted antibodies: a case report and systematic review of literature 159
Application of the international criteria for optic neuritis in the Acute Optic Neuritis Network 156
Anti-MOG-associated demyelinating disorders: two sides of the same coin 156
Late presentation of NMOSD as rapidly progressive leukoencephalopathy with atypical clinical and radiological findings 154
GABA(A) receptor autoimmunity after alemtuzumab treatment for multiple sclerosis 153
Cognitive Profile in Adult Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Comparative Study With Multiple Sclerosis 152
Diagnostic features of initial demyelinating events associated with serum MOG-IgG 151
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 150
Atypical myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review 150
Gender disparity in editorial boards of journals in neurology 150
Oligoclonal bands: clinical utility and interpretation cues 150
Epileptic seizures of suspected autoimmune origin: a multicentre retrospective study 148
Clinical Neuropathology image 1-2018: Golgi silver staining, the black reaction 147
Autoimmune encephalitis misdiagnosis and mimics 145
HCV-related nervous system disorders. 145
Is there a correlation between MOGAD and SARS-CoV-2 infection? 144
Inter-center agreement in the interpretation of oligoclonal bands 143
A score that predicts aquaporin-4-IgG positivity in patients with longitudinally extensive transverse myelitis 141
Neurofilament light chain levels in patients with antibodies to myelin oligodendrocyte glycoprotein (MOG-Abs) 141
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 139
The Acute Optic Neuritis Network (ACON): Study protocol of a non-interventional prospective multicenter study on diagnosis and treatment of acute optic neuritis 139
GFAP as a marker of astrocytic damage correlated with medication overuse in migraine 137
Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015 137
Mechanisms of nerve damage in neuropathies associated with hematological diseases: lesson from nerve biopsies 136
Brain stimulation as a therapeutic tool in Amyotrophic Lateral Sclerosis: current status and interaction with mechanisms of altered cortical excitability 135
Brain Volume Measures in Adults with MOG-Antibody-Associated Disease: A Longitudinal Multicenter Study 133
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 132
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 131
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 129
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD) 129
Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease 128
Peripheral neuropathy and central nervous system involvement in cryoglobulinenia. 128
Cerebrospinal fluid analysis and the determination of oligoclonal bands 128
Autoimmune encephalitis: a retrospective monocentric experience 128
Review of West Nile virus epidemiology in Italy and report of a case of West Nile virus encephalitis. 127
l-dopa-induced off: functional overlay in Parkinson disease 126
Diagnostics of autoimmune encephalitis associated with antibodies against neuronal surface antigens 126
Persistence of anti-NMDAR antibodies in CSF after recovery from autoimmune encephalitis 125
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses 125
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 124
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 123
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 123
Infectious neuropathies 123
Serum neurofilament to Magnetic Resonance Imaging lesion area ratio differentiates spinal cord infarction from acute myelitis 122
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis 120
Investigating the association between neoplasms and MOG antibody-associated disease 120
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 119
HCV-related central and peripheral nervous system demyelinating disorders. 117
Diagnostics of dysimmune peripheral neuropathies 116
Management of antibody-mediated autoimmune encephalitis in adults and children: literature review and consensus-based practical recommendations 116
Exposure to TNF inhibitors is rare at MOGAD presentation 116
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 116
NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders 115
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 114
Diagnostics of anti-MAG antibody polyneuropathy 113
Peripheral neuropathies during the COVID-19 pandemic: is there a relation? 113
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 112
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 111
Sporadic Creutzfeldt-Jakob disease: prion pathology in medulla oblongata-possible routes of infection and host susceptibility. 111
Prevalence, incidence, and season distribution of MOG antibody-associated disease in the province of Verona, Italy 111
Serum Neurofilament Light Chain in NMOSD and Related Disorders: Comparison According to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies Status 110
Lymphomatosis cerebri and anti-NMDAR antibodies: A unique constellation 110
Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers 110
Brentuximab vedotin-induced peripheral neuropathy: looking at microtubules 109
Totale 15.477
Categoria #
all - tutte 77.671
article - articoli 75.860
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 483
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.328
Totale 155.342


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022541 0 0 2 119 19 32 15 37 32 37 71 177
2022/20231.939 115 188 160 343 141 470 25 131 232 33 63 38
2023/20241.279 47 82 137 136 112 304 56 76 21 71 167 70
2024/20253.180 149 198 120 493 155 117 188 199 534 245 258 524
2025/202610.421 647 675 639 1.612 2.775 652 920 658 767 549 220 307
2026/2027740 205 317 218 0 0 0 0 0 0 0 0 0
Totale 20.469